Alzheimer’s Disease and Brain Awareness Month and The Longest Day.
The resolution highlights the alarming statistics surrounding Alzheimer’s disease in California, which is home to approximately 690,000 residents diagnosed with the condition. It emphasizes the anticipated growth in the number of Alzheimer's patients over the next two decades, particularly among communities of color, indicating a pressing need for expanded resources and support systems. The declaration aims not only to raise awareness but also to stimulate community action and fundraising for research, treatment, and support for individuals and caregivers involved in the lengthy and challenging journey of this disease.
ACR 64 is an Assembly Concurrent Resolution introduced by Assemblymember Bains that declares June 2023 as Alzheimer's Disease and Brain Awareness Month in California. The resolution aims to educate the public on the impacts of Alzheimer's disease which affects a significant number of families and communities across the state. The bill also designates June 21, 2023, as The Longest Day, encouraging citizens to engage in activities that honor those affected by the disease and support related advocacy efforts. The resolution is reflective of California's commitment to public health and the wellbeing of its residents, particularly those living with Alzheimer's and their caregivers.
Overall, the sentiment surrounding ACR 64 appears largely positive, with widespread support for the efforts to raise awareness and promote understanding of Alzheimer’s disease. Legislators and advocates view the declaration as a critical step toward mobilizing resources and encouraging public engagement. However, underlying the enthusiasm for recognition is an acknowledgment of the challenges that lie ahead in addressing the growing impact of Alzheimer’s on families and healthcare systems, as well as concerns regarding adequate funding and services for affected individuals.
While ACR 64 is a non-controversial measure that focuses on awareness and advocacy rather than specific legislative changes, it underscores the urgent need for legislative attention and action regarding healthcare support for Alzheimer’s patients. Some elements of contention may arise in discussions about resource allocation and the balancing of funding toward Alzheimer’s research and caregiver support versus other pressing health issues. The bill's supportive nature likely preempts significant opposition, but it serves as a platform for broader discussions on health equity and service provision for disproportionately affected communities.